People with diabetes who rely on Sanofi’s popular long-acting insulin pen have had to become pharmacy scouts in recent weeks due to supply issues. Por exemplo, the Lantus Solostar pen, containing 3 milliliters of insulin glargine, has been running low for several weeks because of increased demand ‘driven by broader market dynamics,’ a Sanofi spokesperson told STAT.
Increased Demand Strains Supply
According to Sanofi, the shortage is not technically considered a shortage by the Food and Drug Administration. No entanto, patients are having trouble finding the medication. A Sanofi spokesperson said: ‘Our priority is ensuring patients have access to their medications. This is a temporary situation that we anticipate will improve over the coming weeks.’
Patients Become Pharmacy Scouts
In recent weeks, individuals with diabetes have had to call multiple pharmacies or travel farther to locate the Lantus Solostar pen. Além disso, some have reported delays in refills, forcing them to manage their glucose levels more carefully. A situação destaca a fragilidade das cadeias de suprimento de insulina, mesmo para produtos amplamente utilizados.
Sanofi’s Response and Outlook
Sanofi emphasized that the issue stems from a surge in demand rather than a manufacturing problem. Consequentemente, the company expects the situation to resolve in the coming weeks. Todavia, patients are advised to plan ahead and consult their healthcare providers if they cannot find their usual insulin.
If you or someone you know is affected, consult a healthcare professional for guidance on alternative treatments or management strategies. Por exemplo, healthcare providers can help adjust dosages or recommend other insulin products if necessary.
Frequently Asked Questions
What is causing the shortage of Lantus Solostar insulin pens?
The Lantus Solostar pen containing 3 milliliters of insulin glargine has been running low due to increased demand ‘driven by broader market dynamics,’ according to a Sanofi spokesperson.
Is the Lantus Solostar shortage officially recognized by the FDA?
No, the issue is not technically considered a shortage by the Food and Drug Administration.
How long is the Lantus Solostar shortage expected to last?
A Sanofi spokesperson stated that this is a temporary situation and they anticipate improvement over the coming weeks.
